-
STEMart announced the launch of its new Force Degradation Services.
Jan 21, 2024
-
Jan 21, 2024
-
Jan 21, 2024
-
Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.
Jan 17, 2024
-
Jan 18, 2024
-
Jan 17, 2024
-
Jan 17, 2024
-
Chong Toh Ying has more than 16 years’ experience managing large datasets and building and leading software engineering teams that deliver fast and accurate results.
Jan 16, 2024
-
Huateng Pharm offers Fluralaner (CAS NO.: 864731-61-3) and Sarolaner (CAS NO.: 1398609-39-6) from laboratory-scale development to commercial production.
Jan 16, 2024
-
PathAI, a leading AI-powered precision pathology company, has concluded a year marked by significant growth and advancements. The company developed and launched over 20 new AI products across oncology, MASH/MASLD and IBD; launched the AISight® image management system (IMS); distributed the AISight platform and IMS to a growing footprint of more than 50 labs globally; expanded clinical trial services to encompass MASH/MASLD, IBD and oncology; and honed its leadership team to drive biopharma business, regulatory strategy, and growth initiatives. Moreover, PathAI established key partnerships, presented new data at major industry conferences, and was recognized through several industry awards. The culmination of these 2023 achievements serves to further revolutionize the field of pathology, bringing more AI-driven tools to drug development and diagnostics.
Jan 15, 2024
-
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy (CGT) innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.
Jan 15, 2024
-
Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.
Jan 15, 2024
-
Jan 15, 2024
-
Jan 15, 2024
-
Jan 7, 2024
-
Dec 12, 2023
-
New HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high throughput, high quality analytical performance
Jan 3, 2024
-
Dec 26, 2023
-
Dec 22, 2023
-
Dec 11, 2023